Kristin Jensen's articles Biotechnology GSK adds to COPD drug push with Empirico deal GSK is shelling out $85 million up front, and possibly $745 million overall, for an RNA-based therapy it sees helping a "broad spectrum" of people with the chronic lung condition. Written by Kristin Jensen October 29, 2025October 29, 2025 Saving Bookmark this article Bookmarked
Biotechnology GSK adds to COPD drug push with Empirico deal GSK is shelling out $85 million up front, and possibly $745 million overall, for an RNA-based therapy it sees helping a "broad spectrum" of people with the chronic lung condition. Written by Kristin Jensen October 29, 2025October 29, 2025 Saving Bookmark this article Bookmarked
